CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −521 | 4,169 | ||
| 2024-03-14 | Yocca Frank Chief Scientific Officer | Option exercise 10b5-1 | +521 | 11,580 | ||
| 2024-03-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units 10b5-1 | −521 | 4,169 | ||
| 2023-12-14 | Yocca Frank Chief Scientific Officer | Option exercise | +521 | 11,059 | ||
| 2023-12-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −521 | 4,690 | ||
| 2023-12-14 | Mehta Vimal CEO and President | Option exercise | +2,609 | 32,222 | ||
| 2023-12-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −2,609 | 23,485 | ||
| 2023-12-14 | Rodriguez Javier See Remarks | Option exercise | +521 | 5,913 | ||
| 2023-12-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −521 | 4,690 | ||
| 2023-12-14 | Steinhart Richard I Chief Financial Officer | Option exercise | +521 | 3,063 | ||
| 2023-12-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −521 | 4,690 | ||
| 2023-12-14 | O'Neill Vincent Chief Medical Officer | Option exercise | +521 | 2,802 | ||
| 2023-12-14 | O'Neill Vincent Chief Medical Officer | Option exercise · Restricted Stock Units | −521 | 4,690 | ||
| 2023-09-14 | Yocca Frank Chief Scientific Officer | Option exercise | +521 | 10,538 | ||
| 2023-09-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −521 | 5,211 | ||
| 2023-09-14 | Steinhart Richard I Chief Financial Officer | Option exercise | +521 | 2,542 | ||
| 2023-09-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −521 | 5,211 | ||
| 2023-09-14 | Rodriguez Javier See Remarks | Option exercise | +521 | 5,392 | ||
| 2023-09-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −521 | 5,211 | ||
| 2023-09-14 | O'Neill Vincent Chief Medical Officer | Option exercise | +521 | 2,281 |
Page 16 of 27 · 521 trades